Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comDescription:
68Ga-PSMA-11 is a widely used radiotracer targeting PSMA. In this study, we investigated the diagnostic efficacy of 68Ga-PSMA-11 PET imaging (PET/CT or PET/MRI) in patients with newly diagnosed, treatment-naive prostate cancer, and performed a head-to-head comparison with multi-parameter magnetic resonance imaging (mpMRI).
Sponsor:
First Affiliated Hospital of Fujian Medical University
Phase:
Phase 2/3
Contacts:
Weibing Miao, MDmiaoweibing@126.com
86-0591-87981618
Government Study Link:
NCT07209878 - Click here to see study onClinicalTrials.gov
Help us improve your experience